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Background: Sjögren’s syndrome (SS) is an autoimmune disease related to two common symptoms: dry mouth 
and eyes. Although, xerostomia and hyposialia have been frequently reported in these patients, not many studies 
have evaluated other oral manifestations. The aim of this systematic review was to investigate prevalence rates of 
oral lesions (OL) in SS patients and to compare it to a control group (CG), when available.
Material and Methods: An exhaustive search of the published literature of the Pubmed, Scopus, Web of Science 
and the Cochrane Library databases was conducted according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses Protocols (PRISMA-P) for relevant studies that met our eligibility criteria (up to 
September 1st 2017). 
Results: Seventeen cross-sectional studies and one cohort study were finally included. The results showed that SS 
patients presented more OL compared to non-SS patients. The most frequent types of OL registered in primary 
and secondary SS were angular cheilitis, atrophic glossitis, recurrent oral ulcerations and grooves or fissurations 
of the tongue, also when compared to a CG. 
Conclusions: OL are common and more frequent in SS patients when compared to a CG. This may be a conse-
quence of low levels of saliva. More studies where these OL and all the possible cofounding factors are taken into 
account are needed. 
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Introduction
Sjögren’s syndrome (SS) is one of the most frequent au-
toimmune rheumatic diseases. It affects 0.5-1% of the 
population, occurring more middle-aged women than 
in men, with a ratio of 9:1 (1). Although it can appear at 
any age, it usually arises between the fourth and sixth 
decade of life. SS is a systemic exocrinopathy of un-
known aetiology, which mainly affects the lacrimal and 
salivary glands giving rise to dry eyes and hyposaliva-
tion. It may manifest as primary SS (pSS), which occurs 
as an isolated disease, or as secondary SS (sSS) when it 
appears simultaneously with other autoimmune disease 
(1-3). There have been many classification criteria sug-
gested for pSS (4,5). Nowadays, the most widely used is 
the one proposed by the American-European Consen-
sus Group in 2002 (6). Other diagnosis criteria also ac-
cepted are the ones proposed by the American College 
of Rheumatology and the Sjögren’s International Col-
laborative Clinical Alliance for pSS (7).
Saliva has an important role in preserving oral health. 
Therefore, hyposalivation (or hyposialia) frequently 
increases the risk for different oral problems such as 
tooth decay, periodontal disease or fungal infections 
(8-13). Tongue alterations and non-specific ulceration 
have also been reported (9,14). The association between 
SS and oral lesions of autoimmune aetiology as lichen 
planus, recurrent aphtous stomatitis, pemphigus vulgar-
is and mucous membrane pemphigoid remains unclear 
(15).
This is the first systematic review that unifies all the oral 
lesions (OL) -non-xerostomia and/or hyposalivation- 
shown in the SS patients. The objective of the present 
study was to evaluate which OL are the most frequent 
in SS patients and compare them with a control group 
(CG). Knowing this, future dental protocols could be 
carried out, with the aim of improving SS patient’s oral 
health and quality of life.
Material and Methods 
This systematic review was conducted according to the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Protocols (PRISMA-P) 2015 statement 
(16).
-Focused question
Based on the PRISMA guidelines, 2 focused PICO 
(population, intervention, comparison, and outcome) 
questions were constructed: 1) Which are the most fre-
quent OL (non-xerostomia and/or hyposalivation) in SS 
patients? 2) Do SS patients have a higher prevalence of 
these OL when compared to a CG?
-Search Strategy
A comprehensive search of the scientific literature was 
conducted without date restriction until September 1st 
2017, in the following databases: PubMed/MEDLINE, 
Scopus, Web of Science and The Cochrane Library by 
two independent researchers (JS, JGS). The search strat-
egy used was: (“Sjögren syndrome” OR “Sjögren’s syn-
drome”) AND (“oral manifestations” OR “oral lesions” 
OR “mucosal lesions” OR “oral diseases” OR “oral 
pathology” OR “oral mucosal alterations” OR “oral re-
percussions”) according to each database (Fig. 1). Fur-
thermore, an additional hand search was performed to 
find potential eligible studies as reference lists of review 
articles and relevant studies. 
-Study selection 
•Inclusion criteria. Full-text articles were included re-
gardless of time period of study and year of publication.
Types of studies. The studies included had to be (a) orig-
inal articles published in scientific journals, (b) cross-
sectional or cohort studies, (c) comparative studies (SS 
group and CG), if available,  (d) only in humans, and (e) 
written in English language. 
Types of population. Individuals with SS that could 
have pSS and sSS (no restriction for SS diagnosis clas-
sification criteria was applied). CG population had to be 
healthy patients.
Outcomes. We considered oral alterations, oral manifes-
tations and oral repercussions as OL. Neither xerosto-
mia nor hyposialia were included as OL. In addition, we 
did not include dental lesions or periodontal disease. We 
considered oral candida lesions when clinical changes, 
such as angular cheilitis, atrophic glossitis, erythema-
tous candidiasis, pseudomembranous candidiasis, or 
median rhomboid glossitis were described. We did not 
consider only positive cultures as OL. The studies must 
evaluate the presence of oral mucosal lesions and spec-
ify the number and/or percentage in the SS group, and 
the CG, if available.
•Exclusion criteria. (a) Those articles published in a 
language other than English, and (b) review articles, 
experimental studies, case reports, commentaries and 
letters to the Editor.
-Data collection and extraction 
Two independent researchers (JS and JGS) compared 
search results to ensure completeness and then du-
plicates were removed. Both reviewers individually 
screened all full title and abstract of the identified ar-
ticles. Differences in eligible studies were resolved by 
discussion with a third reviewer (RMLP). Relevant 
full-text articles were obtained, and checked for eligi-
bility using the following standard abstraction forms: 
first authors, journal, country in which was conducted, 
title of the paper, type of study, recruitment of patients, 
sample characteristics (population, age, and gender of 
SS patients and CG, when available), type of SS, diag-
nosis criteria for SS, and oral mucosal diseases diagno-
sis criteria (Table 1, 1 continue). In Table 2, 2 continue, 
we reported the prevalence of the different OL in SS 
patients and CG and, the statistical signification if there 
was CG, and it was available.  
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Fig. 1: Flow diagram of the literature search, according to the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses (PRISMA).
-Quality Assessment
The Joanna Briggs Institute Prevalence Critical Ap-
praisal Tool (JBI) for Studies Reporting Prevalence 
Data (17) was used to evaluate the methodological qual-
ity of the selected studies (Table 3).
A study was considered to have a low quality assess-
ment if a 0-5 criteria was met, and high quality assess-
ment if studies met 5-10 criteria. Two reviewers (JS and 
JGS) conducted independently a critical appraisal, com-
paring and discussing afterwards their results. If the 
two reviewers disagreed on the final critical appraisal, a 
third reviewer (RMLP) was required.
-Categorization of Studies
In order to clarify the results, we categorized the stud-
ies in different groups: 1) studies which determine the 
prevalence of any type of OL, 2) studies which only de-
termine the prevalence of Candida albicans lesions and 
3) studies which determine the prevalence of OL of au-
toimmune aetiology.
-Data items and synthesis of results
The prevalence of oral mucosal lesions from the in-
cluded studies was presented as a percentage. This 
percentages and their statistical significance, when 
available, shown along with the number of SS and CG 
(when available), were recorded in Table 2, 2 continue. 
A meta-analysis was not possible to carry out due to the 
differences between the selected papers: different types 
of SS, different SS diagnosis criteria, lack of agreement 





The search strategy yielded 467 results, of which 310 
remained after removing duplicates. We screened all 
the titles, excluding those written in any language other 
than English, and those that were out of scope of re-
view, obtaining a total of 56 eligible publications. Then, 
two independent researchers (JS and JGS) reviewed all 
the titles and abstracts, and excluded those that were 
reviews, case reports or did not specify oral disorders. 
Due to the study populations in the papers carried out 
by Soto-Rojas (14,18) were exactly the same (with the 
same result data) we considered both publications as 
only one article in order to unify the oral manifesta-
tions. The same resolution was taken for those carried 
out by Rhodus (19,20). Thirty-six studies, which did not 
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Table 1: Study characteristics.
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Table 1 continue: Study characteristics.
CG=Control Group, SS=Sjogren syndrome, pSS=Primary SS, sSS=Secondary SS, CD=Celiac Patients, F=female, AECG=American-Europe-
an Consensus Group, (1)=Identified by their physician, (2)=Sjögren’s syndrome foundation patients.
fulfil the eligibility criteria, were excluded (Appendix 
1). Finally, 18 articles were included in our systematic 
review (3,9,11-15,19,21-24,26-30) (Fig. 1).
-Study characteristics
Seventeen of the eighteen selected articles were cross-
sectional studies and the other one was a cohort study. 
They were published between 1980 and 2016. A total of 
3290 patients were studied: 2426 were SS patients (of 
which known: 2111 had pSS and 216 sSS), 3 of the stud-
ies did not specify the type of SS (MacFarlane et al., 10 
SS patients; Koseki et al., 54 SS patients; and Olate et 
al., 35 SS patients), and 864 patients were CG (Table 1).
The mean age of the subjects ranged from 28.25-62 
years in the SS group and 24-62 years in the CG (Table 
1).
Regarding to gender, in the SS patients the female per-
centage ranged from 81.2% to 100%, and in the CG 
from 87.5% to 100%.  Three articles did not specify the 
gender of the sample (12,28,30).
We did not consider the CG in Patinen et al. study, since 
they were celiac patients; neither in Kindelan et al. 
study (since they were xerostomic controls), nor Yan et 
al. (because they had oral candidiasis) (Table 1).
-Main findings  
The most frequent OL among SS patients was angular 
cheilitis, reported in fifteen of the eighteen selected pa-
pers. Atrophic glossitis was also common, reported in 
ten of the selected papers. Candida manifestations and 
recurrent or chronic oral ulcerations in eight of them; 
and grooves or fissuration of the tongue were reported 
in seven papers. None of the selected papers reflected 
the total prevalence within the SS or the CG patients 
(Table 2).
This is in accordance with what we found when com-
pared to a CG. The types of OL which were significant-
ly more common in SS are: angular cheilitis, (14,28) 
atrophic glossitis (9,28), grooves or fissuration of the 
tongue (9,14), clinical manifestation of candidiasis (14), 
erythematous candidiasis (28) and atrophic mucosa 
(28). Oral manifestations, with its respective percentag-
es, both in SS and CG patients are recorded in Table 2.
-Risk of bias in individual studies
Using the predetermined 10 domains for the method-
ological quality assessment according to the JBI (17), we 
determined ten of the selected papers (3,11,12,14,21,22, 
25,26,29,30) to have a low quality assessment and eight 
of them (9,13,15,19,23,24,27,28) to have a high quality 
assessment. Table 3 shows a more detailed description 
of the articles included.
-Risk of bias within studies 
We detected some sources of information bias. First 
of all, different diagnosis criteria for SS have been 
used along the years. Second of all, some studies did 
not specify how the oral mucosal evaluation was car-
ried out (3,13,19,24,30). Six studies (3,11,23,24,29,30)
did not compare the outcomes with a healthy CG and 
three studies did not specify the gender of the sample 
nor the CG (12,28,30). In addition, three studies did not 
determine the type of SS studied (12,22,30). The studies 
did not take into account the presence of confounding 
factors as smoking and alcohol habits, other diseases or 
drugs intake, and eight of them did not report if the pa-
tients wore dentures (3,13-15 26,27,29,30).
-Risk of bias across studies
Due to the fact that only articles published in English 
were reviewed, bias due to language publication could 
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Study Oral manifestations in SS and CG 
Tapper-Jones et al; 1980 Angular cheilitis: SS 18.7%  pSS 20%  sSS 18.1%  CG 0 
Atrophic glossitis: SS 37.5%  pSS 40%  sSS 36.3%  CG 0 
Macfarlane et al; 1984 Angular cheilitis: SS 50% CG 0 
Atrophic glossitis: SS 90% CG 0 
Hernández et al; 1989 Angular cheilitis: SS 20% 
Atrophic glossitis: SS 44% 
Grooves/ Fissuration of the tongue: SS 52% 
Dorsal tongue erythema: SS 32% 
Patchy erythema (nonlingual): SS 26% 
Removable white plaques: SS 1% 
Lundström et al; 1995 Angular cheilitis: pSS 35% 
Oral candidiasis: pSS 75% 
Recurrent or chronic ulcerations: pSS 40% 
Oral lichenoid lesions: pSS 18% 
Herpes labialis: pSS 2.5% 
Soto-Rojas et al; 1998 Angular cheilitis: pSS 24% sSS 24% CG 0 (pSS vs CG p=0.017; sSS vs CG p=0.012) 
Atrophic glossitis: pSS 62% sSS 76% CG 16% 
Oral candidiasis: pSS 71% sSS 76% CG 23% (pSS vs CG p<0.01; sSS vs CG p<0.001) 
Grooves/ Fissuration of the tongue: pSS 62% sSS 76% CG 16% (pSS vs CG p=0.001; sSS vs CG p<0.001) 
Removable white plaques: pSS 4.76% sSS 6.8% 
Kindelan et al; 1998 Angular cheilitis: pSS 6.2% sSS 16.6% 
Atrophic glossitis: pSS 6.2% 
Oral candidiasis:  pSS 18.75%  sSS 25% 
Denture stomatitis: pSS 6.2%  sSS 8.3% 
Dorsal tongue erythema: sSS 8.3% 
Erythematous candidiasis: sSS 8.3% 
Pedersen et al; 1999 Angular cheilitis: pSS 18.7%  CG 0 
Atrophic glossitis: pSS 68.7%  CG 0 
Oral candidiasis: pSS 18.7%  CG 0 
Recurrent or chronic ulcerations:  pSS 25% CG 0 
Denture stomatitis: pSS 12.5% CG 0 
Mucosal friction: pSS 62.5%  CG 0 
Rhodus et al; 1999 
 
Oral candidiasis: SS 48% CG 0 
Angular cheilitis: SS 81% CG 0 
Removable white plaques: SS 14% CG 0 
Patinen et al; 2004 Recurrent or chronic ulcerations: SS 30% CD+SS 30% 
Oral lichenoid lesions: SS 35% CD+SS 15% 
Leukoplakia: SS 25% CD+SS 5% 
Koseki et al; 2004 Angular cheilitis: SS 44.5% CG 2.6% 
Atrophic glossitis: SS 16.7% CG 13.5% 
Grooves/  Fissuration of the tongue: SS 33.3% CG 2.7% 
Shiny tongue: SS 16.7% CG 0 
Strawberry tongue: SS 5.6% CG 0 
Leung et al; 
2004 
Angular cheilitis: pSS 11.5%  sSS 12% CG 0 
Atrophic glossitis: pSS 7.6% sSS 8% CG 0 
Removable white plaques: pSS 3.8% sSS 4% CG 0 
Erythematous candidiasis: pSS 3.8% sSS 4% CG 0 
Márton et al; 2006 Angular cheilitis: SS 2.04% CG 4.6% 
Atrophic glossitis: SS 34.7% CG 9.3%  (p< 0.01) 
Denture stomatitis: SS 20.4% CG 4.6% 
Grooves/ Fissuration of the tongue: SS 40.8% CG 4.6%  (p<0.01) 
Median rhomboid glossitis: SS 6.1% CG 11.6% 
Geographic tongue: SS 2.04% CG 4.6% 
Black hairy tongue: SS 16.3% CG 4.6% 
Atrophic mucosa: SS 10.2% CG 2.32% 
Fox et al; 2008 Recurrent or chronic ulcerations: PhysR-Pss 41% SFS-PSS  46%   (p<0.05) 
Ergun et al; 2010 Angular cheilitis SS 21.6% CG 0 (p=0.005) 
Atrophic glossitis SS 48.6% CG 10.8%  (p<0.001) 
Recurrent or chronic ulcerations: SS 35.13% CG 0 
Erythematous candidiasis: SS  62.16% CG 13.5%  (p=0.000) 
Atrophic mucosa: SS 75.7% CG 8.1%  (p=0.0001) 
Yan et al; 2011 Angular cheilitis: pSS 6.66% 
Oral candidiasis: pSS 87% 
Denture stomatitis: pSS 3.33% 
Median rhomboid glossitis: pSS 6.6% 
Dorsal tongue erythema: pSS 33.3% 
Likar-Manookin et al; 
2013 
Oral candidiasis: 29.9% 
Recurrent or chronic ulcerations: 
Recurrent aphtous stomatitis: 3.9% 
Chronic Ulcerative Stomatitis: 0.6% 
Lichen planus: 7.1% 
Olate et al; 2014 Angular cheilitis: 14% 
Oral candidiasis: 3% 
Table 2: Oral manifestations in SS and CG.
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Recurrent or chronic ulcerations: 
Ulcers 3% 
Aphtae 31% 
Denture stomatitis: 26% 
Removable white plaques: 0% 
Erythematous candidiasis: 3% 
Blochowiak et al; 2016 Angular cheilitis: pSS 18.2% sSS 22.2% 
Non-specific ulceration: pSS 9.1% sSS 22.2% 
Small Apthae: pSS 13.6%  sSS 11.1% 
Sutton’s apthae: pSS 4.5%  sSS 0 
Grooves/ Fissuration of the tongue: pSS 4.5% sSS 0 
Denture stomatitis: pSS 4.5% sSS 0 
Geographic tongue: pSS 0 sSS 11.1% 
	
Table 2 continue: Oral manifestations in SS and CG.
CG=Control Group, SS=Sjogren syndrome, pSS=Primary SS, sSS=secondary SS, CD=Celiac Patients.
not be ruled out. Even though we searched four data-
bases, we cannot guarantee that some related papers 
might not have been identified. Additionally, not all OL 
were classified in the same way, and not all the studies 
specified if such lesions were reported by a calibrated 
(or always the same) examiner. 
Discussion 
-Summary of evidence
SS is known to be one of the most common rheumat-
ic diseases. To date, there is not a global overview of 
which are the most common OL in these patients, nei-
ther if they appear more frequently in SS than in healthy 
population.
-Main findings
We identified 18 studies reporting prevalence of oral 
mucosal lesions in SS, 10 of them compared to a healthy 
CG. We found surprising the young age of the patients. 
This is due to Pedersen et al. study consider a young 
CG, with a mean age of 24, and Blochowiak et al., a 
study group with a mean age of 28.5. The rest of the 
papers, have a mean age around 50-60 years, which is 
more in accordance with the mean age of this disease 
(Table 1).
In this systematic review, OL were more common among 
SS patients compared to non-SS patients. Angular cheili-
tis was the most frequent OL in SS patients, followed by 
atrophic glossitis; candida lesions; ulcers and grooves or 
fissuration of the tongue (Table 2, 2 continue).
When compared to a CG, the types of OL that appeared 
more frequently in SS with a statistical signification 
were also angular cheilitis; (14,28) clinical manifesta-
tion of candidiasis; (14) erythematous candidiasis;(28) 
atrophic mucosa; (28) atrophic glossitis (9,28) and 
grooves or fissuration of the tongue (9,14). These two 
last tongue alterations are characteristic signs of oral 
mucosal desiccation (9).
Geographic tongue was reported in two of the includ-
ed papers (3,9). Less frequent tongue alterations were 
shiny tongue, strawberry tongue (12), and black hairy 
tongue (9) (Table 2, 2 continue). These tongue condi-
tions, despite the discomfort that they cause, uncom-
monly require treatment. 
The association between SS and OL of autoimmune 
aetiology remains unclear. Likar-Manookin et al. con-
ducted the first study of autoimmune oral diseases in 
pSS. This study observed that 12.3% of pSS patients 
presented autoimmune OL such as lichen planus (7.1%) 
and recurrent aphtous stomatitis (3.9%). Chronic or re-
current ulceration seem to be common among SS pa-
tients: Lundström and Lindström reported a prevalence 
of 40%, which is in accordance with Fox et al. (43%); 
Ergun et al. (35.1% of oral ulcerations in the SS group 
vs 0% in the CG); Pedersen et al. (25%); and Patinen 
et al. (30%). Olate et al. differentiate between ulcers 
(3%) and aphtae, with a higher prevalence: 31%; and 
Blochowiak et al. classify them in non-specific ulcer-
ation (9.1% pSS, 22.2% sSS), small aphtae (13.6% pSS, 
11.1% sSS), and Sutton’s aphtae (4.5% pSS, 0% sSS). In 
these papers the possible aetiology of these ulcerations 
was not given (Table 2, 2 continue).
Less frequently reported were oral lichenoid lesions (18-
35%) (11,26), herpes labialis (2.5%) (11) and oral muco-
sal friction (62%) (25).
-Secondary data
The increased prevalence of OL in SS may be due to 
the impaired salivary gland function in these patients 
(25). Proper levels of saliva allow for lubrication of the 
mucosa, enhance healing of damage tissues, and play 
an essential role in local immunity (10,15,19). Addition-
ally, Pedersen et al. found that oral mucosal changes 
occurred more frequently in patients with the lowest 
salivary flow rates.
It seems to be an inverse relationship between the rate 
of salivary flow and the presence of candidiasis: low 
levels of saliva are related to the presence of candidiasis 
(12,15,29,30). Kindelan et al. and Yan et al. found a sig-
nificant inverse relationship between unstimulated sali-
vary flow and Candida infection. Pseudomembranous 
candidiasis or removable white plaques was reported by 
five authors (18,19,23,27,30). We found interesting the 
fact that among SS patients pseudomembranous candi-
diasis was not common, with a prevalence range in the 
cited articles of 0%-6.8%. Denture wearing is one of the 
major predisposing factors for oral candidiasis, since 
the fitting surface of the denture is the main reservoir 
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of the yeast (28). Nevertheless, neither Soto-Rojas et al. 
nor Pedersen et al. found a direct relationship between 
the presence of oral candidiasis and the use of dentures 
in SS patients.
-Strength and limitations
In order to carry out this systematic review, we con-
ducted a specific search strategy for study selection. We 
included only those studies reporting prevalence of OL 
within the SS patients and, when available, those that 
compared them with a healthy CG. The comparison of 
the studies was limited due to the high degree of hetero-
geneity of OL. Although four databases were searched, 
we cannot rule out having missed relevant studies, also 
due to publication bias. 
Diagnosis criteria of SS have changed periodically 
among the years. Since we did not have publication time 
restriction, different diagnostic criteria has been anal-
ysed among the reviewed studies. This must be taken 
into consideration when interpreting the results. 
Conclusions
In summary, the results of this systematic review showed 
that the prevalence of oral mucosal lesions in SS patients 
is higher than in non-SS patients. Angular cheilitis, 
oral manifestations of candidiasis, ulcerations, atrophic 
glossitis and grooves or fissuration of the tongue were 
the most reported lesions. When compared to a CG, the 
same lesions mention before appeared more frequently 
in SS patients. Some of these lesions (angular cheilitis, 
oral manifestation of candidiasis, groves or fissuration of 
the tongue) seem to be related to the impaired salivary 
gland function: low levels of saliva predispose to these 
kind of OL. Nevertheless, the relationship of other auto-
immune OL as ulcerations remains unclear. This type of 
lesions may be directly attributed to SS and not necessary 
secondary results of the hyposialia. The clinician should 
know which the most frequent OL in SS patients are, in 
order to carry out dental protocols with the objective of 
preventing, diagnosing and treating them correctly, and 
therefore, improve the quality of life of SS patients.
Owing to the high degree of heterogeneity regarding the 
types of SS, diagnosis criteria of SS, and different diag-
nosis criteria of OL, it was difficult to compare the stud-
ies. In addition, the quality assessment showed the low 
quality of most of the existing studies. In our opinion, it 
is necessary to collect other risk factors in these types 
of studies such as alcohol or smoking habits, presence 
of removable prosthesis, oral status, systemic diseases, 
and drugs intake; considering that these factors could 
be also related to the presence of oral diseases. The ma-
jority of the studies reviewed, only determined the pres-
ence of Candida albicans oral manifestation. Therefore, 
we recommend that new studies in which a complete 
oral mucosal evaluation, looking for all possible OL 
ought to be carried out. 
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